Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Bemarituzumab (FUT8-KO)

Catalog No. T9901A-491 Copy Product Info
🥰Excellent
Bemarituzumab (FUT8-KO) is a humanized IgG1 monoclonal antibody targeting FGFR2b that lacks the FUT8 gene. The Fc domain glycan of the Bemarituzumab (FUT8-KO) antibody is devoid of core fucose, resulting in high affinity for human FcγRIIIa.

Bemarituzumab (FUT8-KO)

Copy Product Info
🥰Excellent
Catalog No. T9901A-491

Bemarituzumab (FUT8-KO) is a humanized IgG1 monoclonal antibody targeting FGFR2b that lacks the FUT8 gene. The Fc domain glycan of the Bemarituzumab (FUT8-KO) antibody is devoid of core fucose, resulting in high affinity for human FcγRIIIa.

Bemarituzumab
(FUT8-KO)
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Bemarituzumab (FUT8-KO) is a humanized IgG1 monoclonal antibody targeting FGFR2b that lacks the FUT8 gene. The Fc domain glycan of the Bemarituzumab (FUT8-KO) antibody is devoid of core fucose, resulting in high affinity for human FcγRIIIa.
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
TargetFGFR2b
Chemical Properties
Storage & Solubility Information
StorageShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Bemarituzumab (FUT8-KO) | purchase Bemarituzumab (FUT8-KO) | Bemarituzumab (FUT8-KO) cost | order Bemarituzumab (FUT8-KO)